Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 2 |
2006 | 1 |
2014 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A controlled trial of renal denervation for resistant hypertension.
N Engl J Med. 2014 Apr 10;370(15):1393-401. doi: 10.1056/NEJMoa1402670. Epub 2014 Mar 29.
N Engl J Med. 2014.
PMID: 24678939
Free article.
Clinical Trial.
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, Rocha-Singh K, Townsend RR, Katzen BT, Oparil S, Brar S, DeBruin V, Fahy M, Bakris GL; SYMPLICITY HTN-3 Steering Committee Investigators.
Bhatt DL, et al.
Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18.
Lancet. 2022.
PMID: 36130612
Clinical Trial.
Item in Clipboard
Cyclooxygenase-2 inhibitors: a painful lesson.
Sanghi S, MacLaughlin EJ, Jewell CW, Chaffer S, Naus PJ, Watson LE, Dostal DE.
Sanghi S, et al. Among authors: chaffer s.
Cardiovasc Hematol Disord Drug Targets. 2006 Jun;6(2):85-100. doi: 10.2174/187152906777441803.
Cardiovasc Hematol Disord Drug Targets. 2006.
PMID: 16787194
Review.
Item in Clipboard
A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT, Gottshall SL, Boulet JM, Chaffer SM, Harrison JE, Pearson MS, Turchin PI, Mark L, Garrison AE, Valenzano KJ.
Whiteside GT, et al. Among authors: chaffer sm.
Eur J Pharmacol. 2005 Dec 28;528(1-3):65-72. doi: 10.1016/j.ejphar.2005.10.043. Epub 2005 Nov 28.
Eur J Pharmacol. 2005.
PMID: 16316650
Item in Clipboard
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.
Valenzano KJ, Tafesse L, Lee G, Harrison JE, Boulet JM, Gottshall SL, Mark L, Pearson MS, Miller W, Shan S, Rabadi L, Rotshteyn Y, Chaffer SM, Turchin PI, Elsemore DA, Toth M, Koetzner L, Whiteside GT.
Valenzano KJ, et al. Among authors: chaffer sm.
Neuropharmacology. 2005 Apr;48(5):658-72. doi: 10.1016/j.neuropharm.2004.12.008.
Neuropharmacology. 2005.
PMID: 15814101
Item in Clipboard
Cite
Cite